Recruiting Diabetic Retinopathy Studies in Philadelphia
About Diabetic Retinopathy Clinical Trials in Philadelphia
Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.
There are currently 1 diabetic retinopathy clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 93 participants. Research is being sponsored by Genentech, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diabetic Retinopathy Clinical Trials in Philadelphia — FAQ
Are there diabetic retinopathy clinical trials in Philadelphia?
Yes, there are 1 diabetic retinopathy clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What diabetic retinopathy treatments are being tested?
The 1 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.
Data updated October 16, 2026 from ClinicalTrials.gov